GoodRx Holdings (GDRX) Free Cash Flow (2019 - 2026)

GoodRx Holdings has disclosed Free Cash Flow across 8 years of filings, most recently posting -$8.7 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$8.7 million, up 29.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $101.1 million (down 21.14% YoY), and the FY2025 annual result was $97.4 million, down 46.67% from the prior year.
• Free Cash Flow came in at -$8.7 million for Q1 2026 at GoodRx Holdings, down from $18.3 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $86.5 million in Q3 2024 to a low of -$12.3 million in Q1 2025.
• The 5-year median for Free Cash Flow is $31.7 million (2022), against an average of $29.3 million.
• Across the five-year window, Free Cash Flow surged 1209.28% in 2024 and slumped 129.21% in 2025, its largest moves.
• GoodRx Holdings' Free Cash Flow stood at $31.7 million in 2022, then tumbled by 89.27% to $3.4 million in 2023, then soared by 1209.28% to $44.6 million in 2024, then sank by 58.95% to $18.3 million in 2025, then tumbled by 147.38% to -$8.7 million in 2026.
• The last three Free Cash Flow figures came in at -$8.7 million (Q1 2026), $18.3 million (Q4 2025), and $20.6 million (Q3 2025), per Business Quant data.